Tech Company Financing Transactions

Mosanna Therapeutics Funding Round

Mosanna Therapeutics closed a $80 million Series A funding round on 6/9/2025. Investors included Broadview Ventures, EQT Life Sciences and Forbion Capital Partners.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

Grellingerstrasse 91
Basel, 4052
CH

Phone

Undisclosed

Website

www.mosanna.com

Email Address

[email protected]

Overview

Mosanna is a Swiss Biotech company based in Basel with a commitment to improving patient outcomes and quality of life in high unmet need diseases, applying a precision medicine approach. We carefully select innovative medicines for further development using the best contract research organisations in the specific specialised field. Our first goal is to bring an effective and well tolerated medicinal nasal spray to Metabolic Obstructive Sleep Apnea patients.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chairman

Bernardus Machielse

        

Chief Executive Officer

Jonathan Talbot

        

Browse more venture capital transactions:

Prev: 6/9/2025: Aiera venture capital transaction
Next: 6/9/2025: Row Zero venture capital transaction

Share this article

About Our Venture Capital Transactions Database

We do our best to document every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary